Multiple Sclerosis Banner

Featured Article

McDonald Criteria Update: Further Distinction Between Relapsing-Remitting, Primary-Progressive MS

McDonald Criteria Update: Further Distinction Between Relapsing-Remitting, Primary-Progressive MS

The 2017 revision takes aim at better differentiating relapsing-remitting and primary-progressive forms of multiple sclerosis.

Latest

AAN: High Fish Intake Linked to Reduced Risk of Multiple Sclerosis

AAN: High Fish Intake Linked to Reduced Risk of Multiple Sclerosis

Compared with consuming fish less than once per month and no supplements, high fish intake was correlated with a significantly reduced risk of multiple sclerosis.

Fingolimod May Help Prevent Brain Volume Loss in Relapsing-Remitting Multiple Sclerosis

Fingolimod May Help Prevent Brain Volume Loss in Relapsing-Remitting Multiple Sclerosis

Participants who were treated with both doses of fingolimod experienced less overall progression of disability than those receiving placebo.

DMT Discontinuation in Older MS Patients: Clinical Outcomes Examined

DMT Discontinuation in Older MS Patients: Clinical Outcomes Examined

Of the total patients, 178 (29.7%) discontinued DMT during the study period with only 1 documented relapse occurring in the discontinuers.

Siponimod Reduces Disability Progression in Secondary Progressive Multiple Sclerosis

Siponimod Reduces Disability Progression in Secondary Progressive Multiple Sclerosis

Further research should focus on establishing whether siponimod exerts its effect on the pathogenic processes associated with disease progression or activity, or both.

Apheresis Associated With Clinical Improvement in Early Active Multiple Sclerosis

Apheresis Associated With Clinical Improvement in Early Active Multiple Sclerosis

The study was unable to verify whether the findings may be applicable for lesion locations other than those found with brain biopsies.

Combined Exercise Training Increases BDNF in Relapsing-Remitting MS

Combined Exercise Training Increases BDNF in Relapsing-Remitting MS

The effect of 8 weeks of combined exercise training on serum BDNF concentration was examined in patients with relapsing-remitting multiple sclerosis.

Smoking Associated With Increased Relapse Rate in Interferon Beta-Treated Relapsing-Remitting MS

Smoking Associated With Increased Relapse Rate in Interferon Beta-Treated Relapsing-Remitting MS

A cohort study evaluated the effects of smoking on disease activity in interferon beta-treated relapsing-remitting multiple sclerosis.

Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS

Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS

The impact of treatment with dimethyl fumarate and fingolimod on lymphocyte and leukocyte count was evaluated in patients with multiple sclerosis.

Reduced Risk for Multiple Sclerosis Linked to Greater Sun Exposure

Reduced Risk for Multiple Sclerosis Linked to Greater Sun Exposure

Risk of multiple sclerosis may be reduced with high sun exposure.

Multiple Sclerosis Drug Zinbryta Withdrawn From the Market

Multiple Sclerosis Drug Zinbryta Withdrawn From the Market

Daclizumab, an interleukin-2 (IL-2) receptor blocking antibody, was approved in May 2016 to treat adults with relapsing forms of MS.

Sign Up for Free e-newsletters

CME Focus